| (210) | Number of the EPO application | 20161276 |
| (220) | Filing date of the EPO application | 2018.01.05 |
| (80) | EPO patent specification publication (B) | EPB nr. 45/2024, 2024.11.06 |
| (110) | EPO patent number | 3722415 |
| (21) | Number of the application | e 2020 1056 |
| (71) | Name(s) of applicant(s), code of the country | IOVANCE BIOTHERAPEUTICS INC., US; |
| (72) | Name(s) of inventor(s), code of the country | WARDELL Seth, US;
BENDER James, US;
LOTZE Michael T., US; |
| (73) | Name(s) of owner(s), code of the country | IOVANCE BIOTHERAPEUTICS INC., US; |
| (54) | Title of the invention | Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C12N 5/0783 (2010.01.01); C12M 1/04 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2020.11.30 |
| (30) | Priority | 201762478506 P, 2017.03.29, US; 201762539410 P, 2017.07.31, US; 201762548306 P, 2017.08.21, US; 201762554538 P, 2017.09.05, US; 201762559374 P, 2017.09.15, US; 201762567121 P, 2017.10.02, US; 201762577655 P, 2017.10.26, US; 201762582874 P, 2017.11.07, US; 201762596374 P, 2017.12.08, US |
| (74) | Patent attorney | (Procedură) FOCŞA Valentin, bd. Renaşterii Naţionale, No. 6, of. 08, MD-2024, mun. Chişinău, Republica Moldova |